1,465
+0.14%
Close of 9 Nov 2026, in JPY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Nippon Chemiphar Co
Its shares trade on Tokyo Stock Exchange under the ticker 4539.T. It has been listed since 1 October 1971. In the fiscal year to 31 March 2026, it reported revenue of ¥33.09bn and net income of ¥198.0m. At that date it held total assets of ¥49.98bn and shareholders' equity of ¥19.51bn.
Nippon Chemiphar Co., Ltd. engages in the healthcare business. The company is headquartered in Chiyoda-Ku, Tokyo-To. The Company’s Pharmaceutical segment is engaged in the manufacture and sale of ethical pharmaceutical products. Other businesses include entrusted safety testing, healthcare and real estate leasing business. The firm mainly operates in Japan and Vietnam.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Pharmaceuticals
- Listed since
- 1 Oct 1971
- Employees
- 872
- Website
- chemiphar.co.jp ↗
Leadership
Pay as last reported
- Mr. Kazushiro YamaguchiPresident, Executive President, Chief Executive Officer, Representative Executive Officer, Representative Director, since 2005
- Mr. Masanori KutsuwadaSenior Managing Executive Officer, Director, since 2009
- Mr. Tomio YamakawaManaging Executive Officer, Director, since 2007
- Mr. Shinichi KudoExecutive Officer, Chief Director of Group Pharmaceutical Sales
- Mr. Hirofumi MiyataExecutive Officer, Director of Human Resources, Manager of President's Office
- Mr. Masahide YasumotoExecutive Officer, Director of Business Planning, Director of Healthcare, Director, since 2008
- Mr. Shinji NakajimaExecutive Officer, Director of Administration
- Mr. Jiro ShimadaExecutive Officer, Senior Director of Reliability Assurance, Senior Director of Group Quality Assurance
- Mr. Kouki HayamizuDirector
- Mr. Yuji HaradaIndependent Director
- Ms. Naoko OmukaiIndependent Director
- Mr. Masaki YoshinoIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Nippon Chemiphar employs 872 full-time employees in Japan and Vietnam.
- The Pharmaceutical segment manufactures ethical pharmaceutical products in Japan.
- The Company operates in the Health Care sector with a focus on Japan and Vietnam.
Weaknesses
- The Company has limited operations outside Japan and Vietnam in the Health Care sector.
- The Pharmaceutical segment relies on ethical pharmaceutical products in Japan.
- The Company's real estate leasing business is a minor segment compared to pharmaceuticals.
Opportunities
- Expanding the entrusted safety testing business in Vietnam could increase market share.
- Growing healthcare demand in Japan presents opportunities for pharmaceutical sales.
- The real estate leasing business in Japan could be expanded to new locations.
Threats
- Competition in the Japanese pharmaceutical market may reduce profit margins.
- Regulatory changes in Vietnam could affect the safety testing business.
- Economic downturns in Japan might decrease healthcare spending.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.